Cited by 89Parkinson's Disease Mechanisms and TreatmentsUbiquitin and proteasome pathwaysNuclear Receptors and Signaling

Structural and Functional Impact of Parkinson Disease-Associated Mutations in the E3 Ubiquitin Ligase Parkin: HUMAN MUTATION

Open access
Fiesel, Fabienne C., Caulfield, Thomas R., Moussaud-Lamodière, Elisabeth L., Ogaki, Kotaro, Dourado, Daniel F.A.R., Flores, Samuel C., Ross, Owen A., Springer, Wolfdieter·2015·Human Mutation

Abstract

Mutations in the PARKIN/PARK2 gene that result in loss-of-function of the encoded, neuroprotective E3 ubiquitin ligase Parkin cause recessive, familial early-onset Parkinson disease. As an increasing number of rare Parkin sequence variants with unclear pathogenicity are identified, structure-function analyses will be critical to determine their disease relevance. Depending on the specific amino acids affected, several distinct pathomechanisms can result in loss of Parkin function. These include disruption of overall Parkin folding, decreased solubility, and protein aggregation. However pathogenic effects can also result from misregulation of Parkin autoinhibition and of its enzymatic functions. In addition, interference of binding to coenzymes, substrates, and adaptor proteins can affect its catalytic activity too. Herein, we have performed a comprehensive structural and functional analysis of 21 PARK2 missense mutations distributed across the individual protein domains. Using this combined approach, we were able to pinpoint some of the pathogenic mechanisms of individual sequence variants. Similar analyses will be critical in gaining a complete understanding of the complex regulations and enzymatic functions of Parkin. These studies will not only highlight the important residues, but will also help to develop novel therapeutics aimed at activating and preserving an active, neuroprotective form of Parkin.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/humu.22808

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The machine-learning classifier had excellent agreement with the established GFP-PRKN ratio algorithm and a combined Z' score of 0.79.

    “There was excellent agreement between the new classifier and the established ‘GFP-PRKN ratio’ algorithm [19, 20, 25, 30] (Fig. 1C, Table S4) but the new classifier was more robust in this screening setting and had a combined Z’ score of 0.79.”

    From miRNA family miR-29 inhibits PINK1-PRKN signaling via ATG9A (2026) · cites this paper as [25]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 60 · Cited by 89

Research works printed but not linked: 52

  1. Caulfield T Devkota B 2012 Motion of transfer RNA from the A/T state into the A-site using docking and simulations Proteins 80 2489 2500 22730134
  2. Caulfield T Medina-Franco JL 2011 Molecular dynamics simulations of human DNA methyltransferase 3B with selective inhibitor nanaomycin A Journal of structural biology 176 185 191 21839172
  3. Caulfield TR Devkota B Rollins GC 2011 Examinations of tRNA Range of Motion Using Simulations of Cryo-EM Microscopy and X-Ray Data J Biophys 2011 219515 21716650 PMC3116532
  4. Caulfield TR Fiesel FC Moussaud-Lamodiere EL Dourado DF Flores SC Springer W 2014 Phosphorylation by PINK1 releases the UBL domain and initializes the conformational opening of the E3 ubiquitin ligase Parkin PLoS Comput Biol 10 e1003935 25375667 PMC4222639
  5. Chaugule VK Burchell L Barber KR Sidhu A Leslie SJ Shaw GS Walden H 2011 Autoregulation of Parkin activity through its ubiquitin-like domain The EMBO journal 30 2853 2867 21694720 PMC3160258
  6. Cheatham TE III Young MA 2001 Molecular dynamics simulation of nucleic acids: Successes, limitations and promise Biopolymers 56 232 256 11754338
  7. Chew KC Matsuda N Saisho K Lim GG Chai C Tan HM Tanaka K Lim KL 2011 Parkin mediates apparent E2-independent monoubiquitination in vitro and contains an intrinsic activity that catalyzes polyubiquitination PloS one 6 e19720 21625422 PMC3100294
  8. Cookson MR Lockhart PJ McLendon C O’Farrell C Schlossmacher M Farrer MJ 2003 RING finger 1 mutations in Parkin produce altered localization of the protein Human molecular genetics 12 2957 2965 14519684
  9. Cornell WD Cieplak P Bayly CI Gould IR Merz KM Jr Ferguson DM Spellmeyer DC Fox T Caldwell JW Kollman PA 1994 A second generation force field for the simulation of proteins and nucleic acids Thesis (doctoral in Biophysics) University of California San Francisco
  10. Corti O Lesage S Brice A 2011 What genetics tells us about the causes and mechanisms of Parkinson’s disease Physiological reviews 91 1161 1218 22013209
  11. Doherty KM Silveira-Moriyama L Parkkinen L Healy DG Farrell M Mencacci NE Ahmed Z Brett FM Hardy J Quinn N Counihan TJ Lynch T 2013 Parkin disease: a clinicopathologic entity? JAMA neurology 70 571 579 23459986 PMC4202385
  12. Dourado DF Flores SC 2014 A multiscale approach to predicting affinity changes in protein-protein interfaces Proteins 24975440
  13. Farrer M Chan P Chen R Tan L Lincoln S Hernandez D Forno L Gwinn-Hardy K Petrucelli L Hussey J Singleton A Tanner C 2001 Lewy bodies and parkinsonism in families with parkin mutations Annals of neurology 50 293 300 11558785
  14. Fiesel FC Moussaud-Lamodiere EL Ando M Springer W 2014 A specific subset of E2 ubiquitin-conjugating enzymes regulate Parkin activation and mitophagy differently Journal of cell science 127 3488 3504 24928900 PMC4132391
  15. Flores S Sherman M Bruns C Eastman P Altman R 2010 Fast flexible modeling of macromolecular structure using internal coordinates IEEE Transactions in Computational Biology and Bioinformatics 8 1247 1257 PMC4428339 21778523
  16. Flores SC Sherman MA Bruns CM Eastman P Altman RB 2011 Fast flexible modeling of RNA structure using internal coordinates IEEE/ACM transactions on computational biology and bioinformatics/IEEE, ACM 8 1247 1257 PMC4428339 21778523
  17. Gu WJ Corti O Araujo F Hampe C Jacquier S Lucking CB Abbas N Duyckaerts C Rooney T Pradier L Ruberg M Brice A 2003 The C289G and C418R missense mutations cause rapid sequestration of human Parkin into insoluble aggregates Neurobiology of disease 14 357 364 14678753
  18. Hampe C Ardila-Osorio H Fournier M Brice A Corti O 2006 Biochemical analysis of Parkinson’s disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity Human molecular genetics 15 2059 2075 16714300
  19. Henn IH Gostner JM Lackner P Tatzelt J Winklhofer KF 2005 Pathogenic mutations inactivate parkin by distinct mechanisms Journal of neurochemistry 92 114 122 15606901
  20. Humphrey W Dalke A Schulten K 1996 VMD: visual molecular dynamics J Mol Graph 14 33 38 27 38 8744570
  21. Jorgensen WL Chandrasekhar J Madura JD Impey RW Klein ML 1983 Comparison of simple potential functions for simulating liquid water Journal of Chemical Physics 79 926 935
  22. Kane LA Lazarou M Fogel AI Li Y Yamano K Sarraf SA Banerjee S Youle RJ 2014 PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity The Journal of cell biology 205 143 153 24751536 PMC4003245
  23. Kazlauskaite A Kelly V Johnson C Baillie C Hastie CJ Peggie M Macartney T Woodroof HI Alessi DR Pedrioli PG Muqit MM 2014a Phosphorylation of Parkin at Serine65 is essential for activation: elaboration of a Miro1 substrate-based assay of Parkin E3 ligase activity Open biology 4 130213 24647965 PMC3971407
  24. Kazlauskaite A Kondapalli C Gourlay R Campbell DG Ritorto MS Hofmann K Alessi DR Knebel A Trost M Muqit MM 2014b Parkin is activated by PINK1-dependent phosphorylation of ubiquitin at Ser65 The Biochemical journal 460 127 139 24660806 PMC4000136
  25. Kitada T Asakawa S Hattori N Matsumine H Yamamura Y Minoshima S Yokochi M Mizuno Y Shimizu N 1998 Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism Nature 392 605 608 9560156
  26. Kondapalli C Kazlauskaite A Zhang N Woodroof HI Campbell DG Gourlay R Burchell L Walden H Macartney TJ Deak M Knebel A Alessi DR 2012 PINK1 is activated by mitochondrial membrane potential depolarization and stimulates Parkin E3 ligase activity by phosphorylating Serine 65 Open biology 2 120080 22724072 PMC3376738
  27. Koyano F Okatsu K Kosako H Tamura Y Go E Kimura M Kimura Y Tsuchiya H Yoshihara H Hirokawa T Endo T Fon EA 2014 Ubiquitin is phosphorylated by PINK1 to activate parkin Nature 510 162 166 24784582
  28. Krawetz JP Shinozaki A Varadarajan K Schulten K 1999 NAMD2: Greater scalability for parallel molecular dynamics Journal of Computational Physics 151 283 312
  29. Krieger E Dunbrack RL Jr Hooft RW Krieger B 2012 Assignment of protonation states in proteins and ligands: combining pKa prediction with hydrogen bonding network optimization Methods Mol Biol 819 405 421 22183550
  30. Krieger E Joo K Lee J Lee J Raman S Thompson J Tyka M Baker D Karplus K 2009 Improving physical realism, stereochemistry, and side-chain accuracy in homology modeling: Four approaches that performed well in CASP8 Proteins 77 Suppl 9 114 122 19768677 PMC2922016
  31. Lazarou M Narendra DP Jin SM Tekle E Banerjee S Youle RJ 2013 PINK1 drives Parkin self-association and HECT-like E3 activity upstream of mitochondrial binding The Journal of cell biology 200 163 172 23319602 PMC3549971
  32. MacKerell AD Bashford D Bellott M Dunbrack RL Evanseck JD Field MJ Fischer S Gao J Guo H Ha S Joseph-McCarthy D Kuchnir L 1998 All-atom empirical potential for molecular modeling and dynamics studies of proteins Journal Of Physical Chemistry B 102 3586 3616 24889800
  33. Matsuda N Kitami T Suzuki T Mizuno Y Hattori N Tanaka K 2006 Diverse effects of pathogenic mutations of Parkin that catalyze multiple monoubiquitylation in vitro The Journal of biological chemistry 281 3204 3209 16339143
  34. Narendra D Kane LA Hauser DN Fearnley IM Youle RJ 2010a p62/SQSTM1 is required for Parkin-induced mitochondrial clustering but not mitophagy; VDAC1 is dispensable for both Autophagy 6 1090 1106 20890124 PMC3359490
  35. Ordureau A Sarraf SA Duda DM Heo JM Jedrychowski MP Sviderskiy VO Olszewski JL Koerber JT Xie T Beausoleil SA Wells JA Gygi SP 2014 Quantitative proteomics reveal a feedforward mechanism for mitochondrial PARKIN translocation and ubiquitin chain synthesis Molecular cell 56 360 375 25284222 PMC4254048
  36. Puschmann A 2013 Monogenic Parkinson’s disease and parkinsonism: clinical phenotypes and frequencies of known mutations Parkinsonism & related disorders 19 407 415 23462481
  37. Reblova K Fadrna E Sarzynska J Kulinski T Kulhanek P Ennifar E Koca J Sponer J 2007 Conformations of flanking bases in HIV-1 RNA DIS kissing complexes studied by molecular dynamics Biophys J 93 3932 3949 17704156 PMC2099213
  38. Reblova K Lankas F Razga F Krasovska MV Koca J Sponer J 2006 Structure, dynamics, and elasticity of free 16s rRNA helix 44 studied by molecular dynamics simulations Biopolymers 82 504 520 16538608
  39. Riley BE Lougheed JC Callaway K Velasquez M Brecht E Nguyen L Shaler T Walker D Yang Y Regnstrom K Diep L Zhang Z 2013 Structure and function of Parkin E3 ubiquitin ligase reveals aspects of RING and HECT ligases Nature communications 4 1982 PMC3709503 23770887
  40. Safadi SS Barber KR Shaw GS 2011 Impact of autosomal recessive juvenile Parkinson’s disease mutations on the structure and interactions of the parkin ubiquitin-like domain Biochemistry 50 2603 2610 21348451 PMC3065874
  41. Sarraf SA Raman M Guarani-Pereira V Sowa ME Huttlin EL Gygi SP Harper JW 2013 Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization Nature 496 372 376 23503661 PMC3641819
  42. Schlehe JS Lutz AK Pilsl A Lammermann K Grgur K Henn IH Tatzelt J Winklhofer KF 2008 Aberrant folding of pathogenic Parkin mutants: aggregation versus degradation The Journal of biological chemistry 283 13771 13779 18362144
  43. Sriram SR Li X Ko HS Chung KK Wong E Lim KL Dawson VL Dawson TM 2005 Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin Human molecular genetics 14 2571 2586 16049031
  44. Trempe JF Sauve V Grenier K Seirafi M Tang MY Menade M Al-Abdul-Wahid S Krett J Wong K Kozlov G Nagar B Fon EA 2013 Structure of Parkin Reveals Mechanisms for Ubiquitin Ligase Activation Science 340 1451 1455 23661642
  45. van de Warrenburg BP Lammens M Lucking CB Denefle P Wesseling P Booij J Praamstra P Quinn N Brice A Horstink MW 2001 Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations Neurology 56 555 557 11222808
  46. Vives-Bauza C Zhou C Huang Y Cui M de Vries RL Kim J May J Tocilescu MA Liu W Ko HS Magrane J Moore DJ 2010 PINK1-dependent recruitment of Parkin to mitochondria in mitophagy Proceedings of the National Academy of Sciences of the United States of America 107 378 383 19966284 PMC2806779
  47. Walden H Martinez-Torres RJ 2012 Regulation of Parkin E3 ubiquitin ligase activity Cellular and molecular life sciences: CMLS 69 3053 3067 22527713 PMC11115052
  48. Wauer T Komander D 2013 Structure of the human Parkin ligase domain in an autoinhibited state The EMBO journal 32 2099 2112 23727886 PMC3730226
  49. Wenzel DM Lissounov A Brzovic PS Klevit RE 2011 UBCH7 reactivity profile reveals parkin and HHARI to be RING/HECT hybrids Nature 474 105 108 21532592 PMC3444301
  50. Xu L Lin DC Yin D Koeffler HP 2014 An emerging role of PARK2 in cancer J Mol Med (Berl) 92 31 42 24297497
  51. Zhang C Lee S Peng Y Bunker E Giaime E Shen J Zhou Z Liu X 2014 PINK1 Triggers Autocatalytic Activation of Parkin to Specify Cell Fate Decisions Current biology: CB PMC4143385 25088558
  52. Zheng X Hunter T 2013 Parkin mitochondrial translocation is achieved through a novel catalytic activity coupled mechanism Cell research 23 886 897 23670163 PMC3698636

Authors
Fiesel, F. C., Caulfield, T. R., Moussaud-Lamodière, E. L., Ogaki, K., Dourado, D. F. A. R., Flores, S. C., Ross, O. A., & Springer, W.
Affiliations
  • Mayo Clinic (US)
  • Uppsala University (SE)
Corresponding author
Springer, Wolfdieter
Venue
Human Mutation
Publisher
Wiley
Published
2015-06-03
Volume
36
Issue
8
Pages
774-786
ISSN
1059-7794 (ISSN-L)
OpenAlex
W1894946963
Cited by
89
References
60
Citations by year
2026: 3 · 2025: 2 · 2024: 15 · 2023: 1 · 2022: 7 · 2021: 12 · 2020: 9 · 2019: 8 · 2018: 14 · 2017: 9 · 2016: 8 · 2015: 1
FWCI
7.52
Type
journal article
Language
en
Open access
Locations
  • Human Mutation (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institute of Neurological Disorders and Stroke (NS085070, NS072187)
  • Michael J. Fox Foundation for Parkinson's Research
  • Mayo Clinic
  • Wenner-Gren Foundation
  • Center for Individualized Medicine, Mayo Clinic
  • eSSENCE
  • Foundation for Mitochondrial Medicine
  • Gerstner Family Foundation
  • Marriott Family Foundation
  • Swedish National Infrastructure for Computing (SNIC) at UPPMAX
  • Uppsala University
Topics
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nuclear Receptors and Signaling
Keywords
Parkin, PARK2, Parkinson's disease, E3 ubiquitin ligase, missense mutations, loss-of-function mutations, protein folding, protein aggregation, autoinhibition, protein solubility, structure-function analysis, pathogenicity assessment, neuroprotection
MeSH terms
HeLa Cells, Humans, Models, Molecular, Mutation, Parkinson Disease, Protein Isoforms, Ubiquitin-Protein Ligases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review